| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $1.1B | $1.5B | $2.1B |
| Cost of Revenue | — | — | — | — | — | $2.1B | $2.7B | $4.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | $0.3B | $0.3B | $0.3B | $0.6B |
| Net Income | $0.5B | $0.3B | $0.7B | $0.2B | $0.8B | $0.0B | $0.1B | $0.3B |
| EPS (Basic) | $11.07 | $5.58 | $14.39 | $4.47 | $16.09 | $0.25 | $2.03 | $5.28 |
| EPS (Diluted) | $10.89 | $5.49 | $14.34 | $4.46 | $16.02 | $0.25 | $2.05 | $5.25 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.7B | $22.9B | $23.1B | $25.4B | $21.7B | $22.5B | $26.5B | $30.4B |
| Current Assets | — | — | — | — | — | $19.6B | $24.1B | $24.7B |
| Cash & Equivalents | $3.6B | $3.7B | $3.6B | $3.9B | $3.0B | $3.1B | $3.9B | $3.9B |
| Total Liabilities | $19.3B | $19.8B | $20.2B | $23.1B | $19.7B | $21.0B | $24.9B | $28.1B |
| Current Liabilities | — | — | — | — | — | $10.4B | $11.9B | $11.5B |
| Stockholders' Equity | $3.3B | $3.1B | $2.9B | $2.3B | $2.1B | $1.5B | $1.6B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $1.9B | $2.0B | $1.8B | $1.5B | $1.9B | $1.2B | $2.8B |
| Investing Cash Flow | $-1.4B | $-1.2B | $0.8B | $-5.1B | $-1.7B | $1.8B | $2.9B | $-1.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-0.6B | $-3.1B | $3.3B | $0.6B | $-4.2B | $-4.1B | $-1.2B |